UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target

Blood, 2017-02, Vol.129 (7), p.823-831

2017

Volltextzugriff (PDF)

Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)

Proceedings of the National Academy of Sciences - PNAS, 2008-12, Vol.105 (52), p.20852-20857

2008

Volltextzugriff (PDF)

Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: pathogenetic insights and translational implications

Frontiers in oncology, 2024-04, Vol.14, p.1383741-1383741

2024

Volltextzugriff (PDF)

Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile

Blood, 2013-08, Vol.122 (7), p.1293-1304

2013

Volltextzugriff (PDF)

Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells

Cell reports (Cambridge), 2018-06, Vol.23 (11), p.3127-3136

2018

Volltextzugriff (PDF)

Impact of therapeutic inhibition of oncogenic cell signaling tyrosine kinase on cell metabolism: in vivo-detectable metabolic biomarkers of inhibition

Journal of translational medicine, 2024-07, Vol.22 (1), p.622-12, Article 622

2024

Volltextzugriff (PDF)

Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma

Toxins, 2013-08, Vol.5 (8), p.1402-1421

2013

Volltextzugriff (PDF)

Nucleophosmin/Anaplastic Lymphoma Kinase (NPM/ALK) Oncoprotein Induces the T Regulatory Cell Phenotype by Activating STAT3

Proceedings of the National Academy of Sciences - PNAS, 2006-06, Vol.103 (26), p.9964-9969

2006

Volltextzugriff (PDF)

Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation

Blood, 2014-07, Vol.124 (5), p.761-770

2014

Volltextzugriff (PDF)

Simultaneous inhibition of mTOR-containing complex 1 (mTORC1) and MNK induces apoptosis of cutaneous T-cell lymphoma (CTCL) cells

PloS one, 2011-09, Vol.6 (9), p.e24849

2011

Volltextzugriff (PDF)

STAT3- and DNA Methyltransferase 1-Mediated Epigenetic Silencing of SHP-1 Tyrosine Phosphatase Tumor Suppressor Gene in Malignant T Lymphocytes

Proceedings of the National Academy of Sciences - PNAS, 2005-05, Vol.102 (19), p.6948-6953

2005

Volltextzugriff (PDF)

TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment

Cell reports (Cambridge), 2020-10, Vol.33 (1), p.108221-108221, Article 108221

2020

Volltextzugriff (PDF)

Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication

Blood cancer journal (New York), 2021-02, Vol.11 (2), p.39-14, Article 39

2021

Volltextzugriff (PDF)

The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma

Cancer biology & therapy, 2011-12, Vol.12 (12), p.1019-1022

2011

Volltextzugriff (PDF)

Reports from the 2021 SH/EAHP Workshop on Transformation and Transdifferentiation in Lymphoid Malignancies

American journal of clinical pathology, 2023-06, Vol.159 (6), p.519-521

2023

Volltextzugriff (PDF)

Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity

Blood, 2006-09, Vol.108 (5), p.1744-1750

2006

Volltextzugriff (PDF)

Distinct miRNA profile in prognosis of early CTCL

Blood, 2018-02, Vol.131 (7), p.711-711

Wasik, Mariusz A.

2018

Volltextzugriff (PDF)

ACLY is the novel signaling target of PIP2/PIP3 and Lyn in acute myeloid leukemia

Heliyon, 2020-05, Vol.6 (5), p.e03910-e03910, Article e03910

2020

Volltextzugriff (PDF)

Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells

Cancer discovery, 2017-10, Vol.7 (10), p.1154-1167

2017

Volltextzugriff (PDF)

Dynamic Changes in Gene Mutational Landscape With Preservation of Core Mutations in Mantle Cell Lymphoma Cells

Frontiers in oncology, 2019-07, Vol.9, p.568-568

2019

Volltextzugriff (PDF)

IL-13 as a novel growth factor in CTCL

Blood, 2015-04, Vol.125 (18), p.2737-2738

Wasik, Mariusz A.

2015

Volltextzugriff (PDF)

Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover

Seminars in Immunopathology, 2017-04, Vol.39 (3), p.269-282

2017

Volltextzugriff (PDF)

Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insights

Blood, 2017-12, Vol.130 (23), p.2569-2572

2017

Volltextzugriff (PDF)

Anaplastic Lymphoma Kinase (ALK)-Induced Malignancies: Novel Mechanisms of Cell Transformation and Potential Therapeutic Approaches

Seminars in oncology, 2009-04, Vol.36 (2 Suppl 1), p.S27-S35

2009

Volltextzugriff (PDF)

The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma

Clinical cancer research, 2016-06, Vol.22 (11), p.2684-2696

2016

Volltextzugriff (PDF)

1 – 25 von 297

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(276)
Mit Volltextzugriff
(267)

Publikationsform

Sprache

Englisch
(294)
Polnisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(199)
Life Sciences & Biomedicine
(179)
Humans
(166)
Biological And Medical Sciences
(61)
Medical Sciences
(54)
Animals
(52)
Male
(49)
Cell Line, Tumor
(48)
Hematology
(48)
Mice
(44)
Oncology
(42)
Pathology
(36)
Female
(35)
Lymphoma
(34)
Hematologic And Hematopoietic Diseases
(33)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(30)
Middle Aged
(29)
Tumors
(28)
Adult
(24)
Cell Biology
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target

Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)

Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: pathogenetic insights and translational implications

Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile

Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells

Impact of therapeutic inhibition of oncogenic cell signaling tyrosine kinase on cell metabolism: in vivo-detectable metabolic biomarkers of inhibition

Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma

Nucleophosmin/Anaplastic Lymphoma Kinase (NPM/ALK) Oncoprotein Induces the T Regulatory Cell Phenotype by Activating STAT3

Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation

Simultaneous inhibition of mTOR-containing complex 1 (mTORC1) and MNK induces apoptosis of cutaneous T-cell lymphoma (CTCL) cells

STAT3- and DNA Methyltransferase 1-Mediated Epigenetic Silencing of SHP-1 Tyrosine Phosphatase Tumor Suppressor Gene in Malignant T Lymphocytes

TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment

Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication

The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma

Reports from the 2021 SH/EAHP Workshop on Transformation and Transdifferentiation in Lymphoid Malignancies

Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity

Distinct miRNA profile in prognosis of early CTCL

ACLY is the novel signaling target of PIP2/PIP3 and Lyn in acute myeloid leukemia

Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells

Dynamic Changes in Gene Mutational Landscape With Preservation of Core Mutations in Mantle Cell Lymphoma Cells

IL-13 as a novel growth factor in CTCL

Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover

Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insights

Anaplastic Lymphoma Kinase (ALK)-Induced Malignancies: Novel Mechanisms of Cell Transformation and Potential Therapeutic Approaches

The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma

Suchergebnisse filtern